Patents by Inventor Brendan Leighton

Brendan Leighton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of obesity and essential hypertension and related disorders
    Patent number: 5364841
    Abstract: The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis.
    Type: Grant
    Filed: June 21, 1993
    Date of Patent: November 15, 1994
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Garth J. S. Cooper, Brendan Leighton
  • Treatment of obesity and essential hypertension and related disorders
    Patent number: 5280014
    Abstract: The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis.
    Type: Grant
    Filed: July 18, 1991
    Date of Patent: January 18, 1994
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Garth J. S. Cooper, Brendan Leighton